Logos Global Management LP Dyne Therapeutics, Inc. Transaction History
Logos Global Management LP
- $756 Million
- Q3 2024
A detailed history of Logos Global Management LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 160,000 shares of DYN stock, worth $4.8 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
160,000
Previous 265,000
39.62%
Holding current value
$4.8 Million
Previous $9.35 Million
38.54%
% of portfolio
0.76%
Previous 0.88%
Shares
17 transactions
Others Institutions Holding DYN
# of Institutions
210Shares Held
102MCall Options Held
234KPut Options Held
238K-
Atlas Venture Life Science Advisors, LLC8.02MShares$241 Million35.54% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$222 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.86MShares$206 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.82MShares$204 Million3.9% of portfolio
-
Janus Henderson Group PLC London, X06.81MShares$204 Million0.13% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.55B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...